packageAvatrombopag

avatrombopag

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Avatrombopag is a medicine used to treat thrombocytopenia, a shortage of blood platelets. It is an approved drug and is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q27257213 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:avatrombopag
ATC codes:B02BX08
DrugBank:DB11995
PubChem CID:9852519
Wikidata:Q27257213
formula:C29H34Cl2N6O3S2
molar mass:649.65 g/mol (PubChem CID 9852519)
logP:4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown